Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Blenrep 70 mg powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
belantamab mafodotin
Company:  
GlaxoSmithKline UK See contact details
ATC code: 
L01FX15
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Blenrep Cover letter for additional risk minimisation materials

{healthcare_pro_orange} For Healthcare Professionals

Cover letter when additional risk minimisation materials are distributed to HCPs

{pdf_link}

Eye examination reporting form

{healthcare_pro_orange} For Healthcare Professionals

Form to be used by eye care professionals to record and report eye-related side effects. The reported results should be sent to prescribers to inform decisions on belantamab mafodotin treatment

{pdf_link}

Important Information for Eye Care Professionals: Management of eye-related side effects in patients receiving Blenrep ▼ (belantamab mafodotin)

{healthcare_pro_orange} For Healthcare Professionals

Education booklet for eye care professionals to help them understand and identify the eye-related side effects associated with belantamab mafodotin, so that AEs can be promptly identified and managed according to the SmPC

{pdf_link}

Important Information for Prescribers: Management of eye-related side effects in patients receiving Blenrep ▼ (belantamab mafodotin)

{healthcare_pro_orange} For Healthcare Professionals

Education booklet for prescribers to help them understand and identify the eye-related side effects associated with belantamab mafodotin, so that AEs can be promptly identified and managed according to the SmPC

{pdf_link}

Patient Card

{healthcare_pro_orange} For Healthcare Professionals

A patient card to record care team contact information and eye drop instructions. It can be provided to community pharmacists to assist in selecting the right eye drops.

{pdf_link}

Patient Guide: Important information on eye-related side effects that may occur with Blenrep ▼ (belantamab mafodotin)

{healthcare_pro_orange} For Healthcare Professionals

Education booklet for patients that provides an overview of eye-related side effects and how they will be monitored and managed according to SmPC.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]
OSZAR »